Funding sources M.Z. and S.H.K., none; Y.L. and M.M., the German Registry was funded by the following institutions: Ministry for Research and Technology (Bundesministerium für Forschung und Technologie; BMFT), grant no. 0701 564/4 (1990–1995); Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte; BfArM), grant no. GS 1-68502-200 (1995–1998) and grant no. Z121.01-68502-208 (2001–2002); European Commission, RegiSCAR-project in the 5th Framework, grant no. QLRT-2002-01738 (2002–2005); and a consortium of pharmaceutical companies (Ciba Geigy/Novartis; Hoffmann-La-Roche; Hoechst AG/Hoechst Marion Roussel/Aventis; Sanofi Winthrop/Sanofi Synthelabo; Bayer AG/Bayer Vital; Glaxo Wellcome/GlaxoSmithKline; Schering AG; Goedecke Parke Davis; Pfizer GmbH; Cilag GmbH; Dr Willmar Schwabe; Boehringer Ingelheim; MSD Sharp & Dohme; Merck U.S.A.; Cephalon Inc.; Tibotec B.V.). M.M. received the Else Kröner Memorial Stipendium for support of clinical research through Else Kröner-Fresenius-Foundation (2008–2009).
EPIDEMIOLOGY AND HEALTH SERVICES RESEARCH
Stevens–Johnson syndrome and toxic epidermal necrolysis in patients with lupus erythematosus: a descriptive study of 17 cases from a national registry and review of the literature
Version of Record online: 22 FEB 2012
© 2011 The Authors. BJD © 2011 British Association of Dermatologists
British Journal of Dermatology
Volume 166, Issue 3, pages 575–600, March 2012
How to Cite
Ziemer, M., Kardaun, S.H., Liss, Y. and Mockenhaupt, M. (2012), Stevens–Johnson syndrome and toxic epidermal necrolysis in patients with lupus erythematosus: a descriptive study of 17 cases from a national registry and review of the literature. British Journal of Dermatology, 166: 575–600. doi: 10.1111/j.1365-2133.2011.10705.x
Conflicts of interest None declared.
M.Z. and S.H.K. contributed equally to this study.
- Issue online: 22 FEB 2012
- Version of Record online: 22 FEB 2012
- Accepted manuscript online: 20 OCT 2011 11:14AM EST
- Accepted for publication 13 October 2011
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.